102 related articles for article (PubMed ID: 8671656)
1. Biological characteristics of an immunoregulatory activity secreted by an autoreactive CD4+ T cell clone that suppresses autoimmune diabetes in non-obese diabetic mice.
Tan KN; Min HK; Pan L; Ferrara JL; Myrick KV
Int Immunol; 1996 May; 8(5):689-99. PubMed ID: 8671656
[TBL] [Abstract][Full Text] [Related]
2. Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice.
Han HS; Jun HS; Utsugi T; Yoon JW
J Autoimmun; 1997 Jun; 10(3):299-307. PubMed ID: 9218758
[TBL] [Abstract][Full Text] [Related]
3. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.
Han HS; Jun HS; Utsugi T; Yoon JW
J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive Effects of
Hwang YH; Lee SJ; Kang KY; Hur JS; Yee ST
J Microbiol Biotechnol; 2017 Jun; 27(6):1189-1197. PubMed ID: 28372035
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of cloned macrophage hybridomas. IV. Induction and inhibition of mixed lymphocyte responses.
Ju ST; Dorf ME
J Immunol; 1985 Jun; 134(6):3722-30. PubMed ID: 3157748
[TBL] [Abstract][Full Text] [Related]
6. CD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice.
Akhtar I; Gold JP; Pan LY; Ferrara JL; Yang XD; Kim JI; Tan KN
J Exp Med; 1995 Jul; 182(1):87-97. PubMed ID: 7790825
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of a human T cell hybrid factor on both cell growth and mixed lymphocyte reactivity. Correlation with class II molecule expression.
Trucco M; Shaw S; Korngold R
J Clin Invest; 1985 Sep; 76(3):1032-41. PubMed ID: 2931451
[TBL] [Abstract][Full Text] [Related]
8. The relationship between immune interferon production and proliferation in antigen-specific, MHC-restricted T cell lines and clones.
Hecht TT; Longo DL; Matis LA
J Immunol; 1983 Sep; 131(3):1049-55. PubMed ID: 6193170
[TBL] [Abstract][Full Text] [Related]
9. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.
Amrani A; Verdaguer J; Thiessen S; Bou S; Santamaria P
J Clin Invest; 2000 Feb; 105(4):459-68. PubMed ID: 10683375
[TBL] [Abstract][Full Text] [Related]
10. Interferon-tau inhibits the development of diabetes in NOD mice.
Sobel DO; Ahvazi B; Amjad F; Mitnaul L; Pontzer C
Autoimmunity; 2008 Nov; 41(7):543-53. PubMed ID: 18608174
[TBL] [Abstract][Full Text] [Related]
11. Sodium meta-arsenite prevents the development of autoimmune diabetes in NOD mice.
Lee YS; Kim D; Lee EK; Kim S; Choi CS; Jun HS
Toxicol Appl Pharmacol; 2015 Apr; 284(2):254-61. PubMed ID: 25576766
[TBL] [Abstract][Full Text] [Related]
12. Immunostimulation circumvents diabetes in NOD/Lt mice.
Serreze DV; Hamaguchi K; Leiter EH
J Autoimmun; 1989 Dec; 2(6):759-76. PubMed ID: 2533502
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones.
Paliard X; de Waal Malefijt R; Yssel H; Blanchard D; Chrétien I; Abrams J; de Vries J; Spits H
J Immunol; 1988 Aug; 141(3):849-55. PubMed ID: 2969394
[TBL] [Abstract][Full Text] [Related]
14. Broad induction of immunoregulatory mechanisms after a short course of anti-IL-7Rα antibodies in NOD mice.
Vazquez-Mateo C; Collins J; Fleury M; Dooms H
BMC Immunol; 2017 Mar; 18(1):18. PubMed ID: 28356069
[TBL] [Abstract][Full Text] [Related]
15. Presentation of beta-cell antigens to CD4+ and CD8+ T cells of non-obese diabetic mice.
Shimizu J; Kanagawa O; Unanue ER
J Immunol; 1993 Aug; 151(3):1723-30. PubMed ID: 8101546
[TBL] [Abstract][Full Text] [Related]
16. The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.
Pop SM; Wong CP; He Q; Wang Y; Wallet MA; Goudy KS; Tisch R
Diabetes; 2007 May; 56(5):1395-402. PubMed ID: 17317763
[TBL] [Abstract][Full Text] [Related]
17. Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies.
Serreze DV; Leiter EH
J Immunol; 1988 Jun; 140(11):3801-7. PubMed ID: 2897395
[TBL] [Abstract][Full Text] [Related]
18. Mouse pancreatic beta cells express MHC class II and stimulate CD4(+) T cells to proliferate.
Zhao Y; Scott NA; Quah HS; Krishnamurthy B; Bond F; Loudovaris T; Mannering SI; Kay TW; Thomas HE
Eur J Immunol; 2015 Sep; 45(9):2494-503. PubMed ID: 25959978
[TBL] [Abstract][Full Text] [Related]
19. IL-10 and TGF-beta induce alloreactive CD4+CD25- T cells to acquire regulatory cell function.
Chen ZM; O'Shaughnessy MJ; Gramaglia I; Panoskaltsis-Mortari A; Murphy WJ; Narula S; Roncarolo MG; Blazar BR
Blood; 2003 Jun; 101(12):5076-83. PubMed ID: 12609834
[TBL] [Abstract][Full Text] [Related]
20. Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse.
Herbelin A; Gombert JM; Lepault F; Bach JF; Chatenoud L
J Immunol; 1998 Sep; 161(5):2620-8. PubMed ID: 9725264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
